Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 104 points (-0.6%) at 17,824 as of Wednesday, May 6, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 986 issues advancing vs. 2,035 declining with 119 unchanged. The Electronics industry currently sits down 0.3% versus the S&P 500, which is down 0.3%. A company within the industry that increased today was Taiwan Semiconductor Manufacturing ( TSM), up 0.5%. A company within the industry that fell today was Semiconductor Manufacturing International C ( SMI), up 5.1%. TheStreet would like to highlight 3 stocks pushing the industry higher today: 3. Bio-Rad Laboratories ( BIO) is one of the companies pushing the Electronics industry higher today. As of noon trading, Bio-Rad Laboratories is up $8.10 (6.0%) to $142.79 on heavy volume. Thus far, 258,044 shares of Bio-Rad Laboratories exchanged hands as compared to its average daily volume of 174,500 shares. The stock has ranged in price between $138.11-$147.13 after having opened the day at $140.00 as compared to the previous trading day's close of $134.69. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE. Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. Bio-Rad Laboratories has a market cap of $3.3 billion and is part of the health care sector. Shares are up 13.7% year-to-date as of the close of trading on Tuesday. Currently there is 1 analyst who rates Bio-Rad Laboratories a buy, no analysts rate it a sell, and 1 rates it a hold. TheStreet Ratings rates Bio-Rad Laboratories as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Bio-Rad Laboratories Ratings Report now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.